Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.

Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A, Yuan H, Jiang D, Zhang D, Zangi L, Geva J, Roberts AE, Ma Q, Ding J, Chen J, Wang DZ, Li K, Wang J, Wanders RJ, Kulik W, Vaz FM, Laflamme MA, Murry CE, Chien KR, Kelley RI, Church GM, Parker KK, Pu WT.

Nat Med. 2014 Jun;20(6):616-23. doi: 10.1038/nm.3545. Epub 2014 May 11.

2.

Clopidogrel in infants with systemic-to-pulmonary-artery shunts.

Wessel DL, Berger F, Li JS, Dähnert I, Rakhit A, Fontecave S, Newburger JW; CLARINET Investigators.

N Engl J Med. 2013 Jun 20;368(25):2377-84. doi: 10.1056/NEJMoa1114588.

3.

The Congenital Heart Disease Genetic Network Study: rationale, design, and early results.

Pediatric Cardiac Genomics Consortium, Gelb B, Brueckner M, Chung W, Goldmuntz E, Kaltman J, Kaski JP, Kim R, Kline J, Mercer-Rosa L, Porter G, Roberts A, Rosenberg E, Seiden H, Seidman C, Sleeper L, Tennstedt S, Kaltman J, Schramm C, Burns K, Pearson G, Rosenberg E.

Circ Res. 2013 Feb 15;112(4):698-706. doi: 10.1161/CIRCRESAHA.111.300297.

4.

The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study.

Roberts AE, Nixon C, Steward CG, Gauvreau K, Maisenbacher M, Fletcher M, Geva J, Byrne BJ, Spencer CT.

Am J Med Genet A. 2012 Nov;158A(11):2726-32. doi: 10.1002/ajmg.a.35609. Epub 2012 Oct 8.

PMID:
23045169
5.

Transformation of the recalcitrant pharmaceutical compound carbamazepine by Pleurotus ostreatus: role of cytochrome P450 monooxygenase and manganese peroxidase.

Golan-Rozen N, Chefetz B, Ben-Ari J, Geva J, Hadar Y.

Environ Sci Technol. 2011 Aug 15;45(16):6800-5. doi: 10.1021/es200298t. Epub 2011 Jul 22.

PMID:
21744850
6.

Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery.

Geva T, Gauvreau K, Powell AJ, Cecchin F, Rhodes J, Geva J, del Nido P.

Circulation. 2010 Sep 14;122(11 Suppl):S201-8. doi: 10.1161/CIRCULATIONAHA.110.951178.

7.

Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy.

Limperopoulos C, Tworetzky W, McElhinney DB, Newburger JW, Brown DW, Robertson RL Jr, Guizard N, McGrath E, Geva J, Annese D, Dunbar-Masterson C, Trainor B, Laussen PC, du Plessis AJ.

Circulation. 2010 Jan 5;121(1):26-33. doi: 10.1161/CIRCULATIONAHA.109.865568. Epub 2009 Dec 21.

8.

Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents.

Selamet Tierney ES, Newburger JW, Gauvreau K, Geva J, Coogan E, Colan SD, de Ferranti SD.

J Pediatr. 2009 Jun;154(6):901-5. doi: 10.1016/j.jpeds.2008.12.028. Epub 2009 Feb 12.

PMID:
19217124
9.

Anemia and elevated lead levels in underimmunized inner-city children.

Adams WG, Geva J, Coffman J, Palfrey S, Bauchner H.

Pediatrics. 1998 Mar;101(3):E6.

PMID:
9481025
10.

Social work perspectives in organ procurement.

Geva J, Weinman ML.

Health Soc Work. 1995 Nov;20(4):287-93.

PMID:
8722211
11.

Production of carcinoembryonic antigen from a human colon adenocarcinoma cell line. I. Large-scale cultivation of carcinoembryonic antigen-producing cells on cylindric cellulose-based microcarriers.

Lazar A, Reuveny S, Geva J, Marcus D, Silberstein L, Ariel N, Epstein N, Altbaum Z, Sinai J, Mizrahi A.

Dev Biol Stand. 1987;66:423-8.

PMID:
3582767
12.

Production of carcinoembryonic antigen from a human colon adenocarcinoma cell line. II. Use of monoclonal antibodies to carcinoembryonic antigen for antigen purification and characterization.

Epstein N, Zandani R, Inbar I, Altbaum Z, Lazar A, Reuveny S, Geva J, Marcus D, Mizrahi A, Ariel N.

Dev Biol Stand. 1987;66:429-37.

PMID:
3556272

Supplemental Content

Loading ...
Support Center